$DXCM

Dexcom Inc

  • NASDAQ
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

PRICE

$290 โ–ฒ0.318%

Extented Hours

VOLUME

1,496,194

DAY RANGE

278.3401 - 289.72

52 WEEK

267.57 - 659.45

Join Discuss about DXCM with like-minded investors

profile
@dros #droscrew
recently

Upgrades 1/19: $ABB $AEG $AKAM $ARCO $ARWR $ASTR $ATVI $BBWI $BCC $BMO $CMC $CYRX $DXCM $EA $ENTG $GKOS $HWC $IBKR $KR $LVS $MBWM $OPRT $RKT $RMNI $SBNY $TFC $TNDM $TTWO $UAA $UL $XM $XOM

145 Replies 6 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Friday, October 29, 2021 Futures Up/Down % Last Dow -45.00 0.13% 35,568 S&P 500 -22.25 0.49% 4,565 Nasdaq -139.50 0.88% 15,625 After trading to all-time highs Thursday for the S&P 500, Dow Jones, and Nasdaq Composite (and a 2% gain for the Russell 2000 as well) on strong earnings as well as positive developments on the spending bill in Washington, futures are pulling back. Shares of tech and retail giants Apple (AAPL) and Amazon (AMZN) are lower by 3% and 4% respectively after AAPLโ€™s iPhone and overall revs miss for the quarter and AMZN drops on a Q3 revs miss, lower op income and lower guidance, sending Nasdaq Futures lower by about 1%. Investor sentiment is also starting to turn cautious amid the steady stream of corporate warnings on inflationary pressures and supply chain woes. Big day of inflation data with the personal spending and income for Sept and PCE inflation data expected at 8:30 AM. The 10-year Treasury yield is up around 1.61%, recovering off mid-week lows around the mid 1.5% level. Bitcoin prices are lower holding around the $60K level while oil futures are on track to snap their 8-week winning streak. In Asian markets, The Nikkei Index rises 0.25% to 28,890, the Shanghai Index gains 0.8% to 3,547, and the Hang Seng Index falls =0.7% to 25,377. In Europe, the German DAX is lower -1.2% to 15,500, while the FTSE 100 down -0.5% at 7,210. Market Closing Prices Yesterday The S&P 500 Index gained 44.74 points, or 0.98%, to 4,596.42 The Dow Jones Industrial Average rose 239.79 points, or 0.68%, to 35,730.48 The Nasdaq Composite surged 212.28 points, or 1.39%, to 15,448.12 The Russell 2000 Index advanced 45.49 points, or 2.02% to 2,297.98 Events Calendar for Today 8:30 AM ET Personal Income for Septemberโ€ฆest. (-0.2%) 8:30 AM ET Personal Spending for Septemberโ€ฆprior +0.4% 8:30 AM ET PCE Price Index MoM for September 8:30 AM ET PCE Price Index YoY for September 8:30 AM ET Core PCE Price Index MoM for Septemberโ€ฆest. +0.2% 8:30 AM ET Core PCE Price Index YoY for Septemberโ€ฆest. +3.7% 9:45 AM ET Chicago PMI for Octoberโ€ฆest. 63.5 (prior 64.7) 10:00 AM ET University of Michigan Confidence, Oct-Fโ€ฆest. 71.4 1:00 PM EST Baker Hughes Weekly rig count data Earnings Calendar: Earnings Before the Open: ABBV, AON, B, BAH, CERN, CHD, CHTR, CL, COWN, CVX, DCOM, HUN, IRMD, LHX, PIPR, POR, PSX, PSXP, RUTH, WY, XOM Macro Up/Down Last Nymex 0.34 83.15 Brent 0.37 84.69 Gold -2.95 1,795.95 EUR/USD -0.0029 1.1652 JPY/USD 0.19 113.76 10-Year Note +0.041 1.61% Sector News Breakdown Consumer com (AMZN) shares fall -3%; 3Q EPS $6.12 vs est. $8.92 on sales $110.8B vs est. $111.6B, AWS net sales $16.11B; guides 4Q sales $130-140B vs est. $142B; sees q4 operating income is expected to be between $0 and $3.0 bln, compared with $6.9 bln in q4 2020; in q4, expect to incur several bln dollars of additional costs in consumer business as we manage through labor supply shortages Starbucks (SBUX) Q4 EPS $1.00 vs. est. $0.99; Q4 revs rose 31% to $8.1B vs. est. $8.21B; commits to $20 bln of share repurchases and dividends over next three years; qtrly active Starbucks rewards membership in U.S. approaches 25 mln, up 28% YoY; qtrly comp store sales of 17% globally; qtrly international comp store sales grew 3%; qtrly comp store sales of 22% in U.S.; comp store sales decreased 7% in China Columbia Sportswear (COLM) 3Q EPS $1.52 vs est. $1.33 on revs $804.7Mm vs est. $862Mm; qtrly inventory -7%; guides FY net sales +21.5-23% vs prior +25-26.5% and est. +26.5%, sees FY EPS $4.55-4.80 vs est. $4.65; says believe can achieve mid-teens or better net sales growth in 2022 vs est. +10% Deckerโ€™s Outdoors (DECK) 2Q EPS $3.66 vs est. $4.00 on sales $721.9Mm vs est. $765.9Mm, comps +1%; sees FY EPS $14.15-15.15 vs est. $15.15; Gross margin was 50.9% compared to 51.2% for the same period last year; Deckerโ€™s also said: UGG(R) brand net sales for the second quarter increased 8.0% to $448.4 million compared to $415.1 million for the same period last year. HOKA(R) brand net sales for the second quarter increased 47.0% to $210.4 million compared to $143.1 million for the same period last year. Teva(R) brand net sales for the second quarter increased 4.0% to $28.8 million compared to $27.7 million for the same period last year. Frontdoor (FTDR) 3Q EPS $0.89 vs est. $0.68 on revs $471Mm vs est. $476.5Mm; guides 4Q revs $330-340Mm vs est. $347.7Mm, sees FY revs $1.59-1.6B vs est. $1.62B Mohawk Industries (MHK) Q3 adj EPS $3.95 vs. est. $3.81; Q3 revs $2.817B vs. est. $2.9B; guides Q4 EPS $2.80-$2.90 vs. est. $3.23 Skecherโ€™s (SKX) Q3 EPS $0.66 vs. est. $0.73; Q3 sales rose 19.2% to $1.55B vs. est. $1.63B; guides Q4 EPS $0.28-$0.33 vs. est. $0.34 and year EPS view cut to $2.45-$2.50 from $2.55-$2.65; cuts FY21 revenue view to $6.15B-$6.2B from $6.15B-$6.25B; Direct-to-Consumer sales grew 44.1% and wholesale sales grew 10.5% SkyWest (SKYW) 3Q adj EPS $1.45 vs est. $0.70 on revs $745Mm vs est. $687.7Mm; says experienced a severe outage in October resulting in about 1,700 flight cancelations and expect may impact 4Q results from $15-20Mm pre-tax; Texas Roadhouse (TXRH) Q3 EPS $0.75 vs est. $0.81 on revenue $869.9M vs est. $869.4M; comp sales +30.2% vs 3Q20, +22.3% vs 2019, partially offset by higher food/beverage costs with commodity inflation 13.9% driven by higher beef prices; sees positive comp sales in FY22, commodity cost inflation in high-teens in 1H22 Energy Chevron (CVX) Q3 adj EPS $2.96 vs. est. $2.21; Q3 revs $43B vs. est. $40.52B; posted net income of $6.11B vs. a loss of $207M a year ago; said Q3 average sales price per barrel of crude oil and natural gas liquids was $58, vs $31 a year earlier Dril-Quip (DRQ) 3Q EPS ($0.31) vs est. ($0.14) on revs $83Mm vs est. $85.6Mm, sees 4Q bookings at high end of $40-60Mm range (unchanged from prior view) First Energy (FE) Q3 adj EPS $0.82 vs. est. $0.79; Q3 revs $3.1B in-line with ests; raises FY21 adj EPS view to $2.55-$2.65 from $2.40-$2.60 (est. $2.54) SM Energy (SM) Q3 EPS $0.69 vs. est. $0.13; Q3 revs $760.24M vs. est. $510.61M; Q3 Production was 14.3 MMBoe (155.8 MBoe/d) and was 56% oil; the Company is increasing guidance for 2021 production volumes to 49.5-50.0 MMBoe (135.6-137.0 MBoe/d) Financials Hartford Financial (HIG) Q3 core EPS $1.26 vs. est. $0.86; Net income ROE for the trailing 12-month period ended Sept. 30, 2021 was 12.3% and core earnings ROE* for the same period was 12.5%; the Commercial Lines combined ratio was 101.2 in third quarter 2021 with an underlying combined ratio* of 87.2, a 6.5-point improvement YoY LPL Financial (LPLA) Q3 EPS $1.77 vs est. $1.75 on revenue $2.02B vs est. $2.05B; total advisory and brokerage assets $1.13 trillion (+40% YoY), organic net new assets $27B (+10% annualized) in the qtr, $110B over past 12-months (+14% annualized) Riley Financial (RILY) announced a $4 dividend, composed of a $3 special one-time payout and a doubling of its regular quarterly dividend to $1 Healthcare 4D Molecular (FDMT)75M share Secondary priced at $25.00 AirSculpt Technologies (AIRS) 7M share IPO priced at $11.00 Aura Biosciences (AURA) 5M share IPO priced at $14.00 Entrada Therapeutics (TRDA)075M share IPO priced at $20.00 Sonendo (SONX)8M share IPO priced at $12.00 Valneva (VALN)5M share Secondary priced at $39.42 Acadia Healthcare (ACHC) Q3 adj EPS in-line at $0.72; Q3 revs $587.6M vs. est. $590.9M; Q3 same facility revenue increased 7.9% YoY, including an increase in revenue per patient day of 5.6% and an increase in patient days of 2.2%; same facility adjusted EBITDA margin was 29.0%; narrowed 2021 revenue to $2.295B-$2.315B vs. est. $2.31B CareDX (CDNA) Q3 adj EPS 7c vs est. 1c on revenue $75.6M vs est. $74M; raised FY21 revenue forecast to $290M-$293M from $280M-$290M DaVita Inc. (DVA) 3Q EPS $2.36 vs est. $2.25 on revs $2.94B, says US dialysis treatments averaged 94,509/day; guides FY adj EPS $8.80-9.15 vs est. $9.19 Dexcom (DXCM) Q3 EPS $0.71 vs. est. $0.63; Q3 revs $650.2M vs. est. $617.82; Based on the strong third quarter results, Dexcom is increasing its guidance for fiscal year 2021 revenue, Non-GAAP gross profit margin, Non-GAAP operating margin, and Adjusted EBITDA margin Gilead Sciences (GILD) 3Q adj EPS $2.65 vs est. $1.75 on revs $7.4B vs est. $6.3B; guides FY total product sales $26-26.3B vs est. $25.14B (sees $21.5B ex Veklury); guides FY adj EPS $7.90-8.10 vs est. $7.19 Nextgen health (NXGN) 2Q adj EPS $0.29 vs est. $0.23 on revs $149.3Mm vs est. $143.4Mm; guides FY revs $584-590Mm vs est. $582.4Mm, sees FY adj EPS $0.90-0.96 vs est. $0.93; says may repurchase up to $60Mm of its outstanding shares through March 2023 PTC Therapeutics (PTCT) Q3 EPS loss ($1.89) vs. est. loss ($1.40); Q3 revs $139M vs. est. $126.44M; raises FY21 rev view for DMD franchise to $400M-$420M from $370M-$390M and narrows R&D and SG&A expenses to $815M-$835M from $825M-$855M. ResMed (RMD) 1Q EPS $1.39 vs est. $1.36 on revs $904Mm vs est. $860.9Mm Seagen (SGEN) Q3 EPS ($1.61) vs est. $(0.58) on revenue $424.1M vs est. $383.1M, total net product sales $366.5M (+37% YoY) Stryker (SYK) Q3 adj EPS $2.20 vs. est. $2.28; Q3 revs $4.16B vs. est. $4.23B; Q3 organic net sales increased 4.5%; raises FY21 adjusted EPS view to $9.08-$9.15 from $8.80-$9.20 (est. $9.30); said now expect 2021 organic net sales growth to be in the range of 7% to 8% from 2019 Industrials & Materials Eastman Chemical (EMN) 3Q adj EPS $2.46 vs est. $2.46 on revs $2.72B vs est. $2.6B; guides FY EPS $8.80-9.00 vs est. $9.09, sees FY FCF about $1.1B; says implementing price increases across specialty product lines to offset higher costs, expect to be caught up in early 2022 Ecolab (ECL) to acquire Purolite, a leading global provider of fast-growing, high value separation and purification solutions to life sciences and critical industrial markets; Ecolab to pay approximately $3.7 billion in cash Fortive (FTV) Q3 adj EPS $0.66 vs. est. $0.65; Q3 revs $1.3B vs. est. $1.32B; raises FY21 adj EPS view to $2.70-$2.75 from $2.65-$2.75 (est. $2.72); said Delivered significant margin improvement, strong adjusted operating margin expansion and robust cash flow growth Hub Group (HUBG) Q3 EPS $1.28 vs est. $1.10 on in-line revs $1.08B; raises FY21 EPS $3.90-$4 from $3.50-$3.70 vs est. $3.66, still sees rev growth in the high-teens Huntington Ingalls (HII) 2Q adj EPS $1.71 vs est. $1.17 on revs $537Mm vs est. $375.6Mm L3Harris Technologies (LHX) raises FY21 adjusted EPS view to $12.85-$13.00 from $12.80-$13.00 and lowers FY21 revenue view to approximately $17.9B from $18.1B-$18.5B Mercer Intโ€™l (MERC) 3Q EPS $1.04 vs est. $0.83 on revs $469.7Mm vs est. $452.9Mm Polymetal International PLC (POLY) 2Q adj EPS $0.77 vs est. $0.56 on revs $419Mm vs est. $428.4Mm; guides FY adj EPS $2.30-2.70 vs est. $3.10, sees FY revs $1.675-1.725B vs est. $1.8B Republic Service (RSG) 3Q adj EPS $1.11 vs est. $1.05 on revs $2.93B vs est. $2.84B; guides FY adj EPS $4.10-4.13 from prior $4.00-$4.05 and vs est. $4.05 Terex Corp. (TEX) 3Q EPS $0.67 vs est. $0.72 on sales $993.8Mm vs est. $1.0B; guides FY sales $3.85B vs est. $3.86B, sees FY EPS $2.75-2.85 vs est. $2.82 Werner Enterprise (WERN) Q3 EPS $0.94 vs. est. $0.95; Q3 revs $702.9M vs. est. $700.8M S. Steel (X) announces a $300 million stock repurchase program and increases its quarterly dividend to $0.05 per share; Q3 adjusted EPS $5.36 tops consensus $4.85; Q3 revs $5.96B vs. est. $5.79B

55 Replies 13 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, October 28, 2021 Futures Up/Down % Last Dow 54.00 0.15% 35,443 S&P 500 11.25 0.26% 4,556 Nasdaq 74.50 0.47% 15.662 U.S. futures are looking at a rebound after a late day swoon erased record gains for stocks, as markets again await another earnings barrage, with yesterday and today the two busiest days of the quarter. Drama out of Washington D.C. also adding to the volatility as investors remain hopeful on a spending bill. As for Wednesday, a midday all-time high for the Nasdaq 100 was marred by a late day sell-off in U.S. stocks, as the S&P 500 and Dow each retreated from records set just the previous day, led by weakness in energy stocks as oil prices tumbled from 7-year highs and long-dated Treasury yields also slumped, with the 30-year falling as much as 10bps below 2%. Corporate earnings have generally been better-than-expected, but constant reminders about rising costs, supply-chain issues, and labor shortages on conference calls brings into question the strength of markets going forward. Couple that with expectations for the Fed to begin its asset tapering plans in November and chances of interest rate hikes in mid-2022 to help prevent inflation getting further out of hand remains a market concern. Shares of Dow components McDonaldโ€™s, Coca-Cola and Microsoft rallied behind strong earnings. In fact, the Nasdaq outperformed behind large cap winners (TSLA, GOOGL MSFT, AMZN), though breadth was decisively negative and SmallCaps plunged with the Russell 200 falling nearly 2%. President Bidenโ€™s infrastructure and social-spending plans still remain โ€œup-in-the-airโ€ which also adds uncertainty. In Asian markets, The Nikkei Index fell about 1% to 28,820, the Shanghai Index slipped -1.23% to 3.518 and the Hang Seng Index dipped about -0.25% to 25,555. In Europe, the German DAX is down -0.15% at 15,680, while the FTSE 100 is also down roughly -0.2% at 7,240. Market Closing Prices Yesterday The S&P 500 Index dropped -23.11 points, or 0.51%, to 4,551.68 The Dow Jones Industrial Average fell -266.19 points, or 0.74%, to 35,490.69 The Nasdaq Composite little changed, or 0.00%, to 15,235.84 The Russell 2000 Index declined -43.58 points, or 1.90% to 2,252.49 Events Calendar for Today 8:30 AM ET Weekly Jobless Claimsโ€ฆest. 290K 8:30 AM EST Continuing Claimsโ€ฆest. 2.415M 8:30 AM ET Gross Domestic Product (GDP) for Q3-Aโ€ฆest. 2.7% (down from prior) 8:30 AM ET GDP Consumer Spending for Q3-Aโ€ฆprior month 12.0% 8:30 AM ET GDP Price Deflator for Q3โ€ฆest. 5.5% 8:30 AM ET Core-PCE Prices Advance for Q3โ€ฆest. 4.5% 10:00 AM ET Pending Home Sales MoM for Septemberโ€ฆest. 0% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Kansas City Fed Manufacturing for October 1:00 PM ET U.S. to sell $62 bln 7-year notes Earnings Calendar: Earnings Before the Open: AB, ABMD, ADS, AEP, AGCO, ALNY, AMT, AOS, ATI, BAX, BC, BSIG, BTU, CARR, CAR, CBRE, CBZ, CFR, CG, CMCO, CMCSA, CMS, CNX, COLB, CONE, COOP, COR, CWT, DBD, EME, EXP, FCN, GPI, GVA, HBAN, HSY, IBP, ICE, ITW, KBR, KDP, KEX, LECO, LH, LKQ, MA, MCO, MDD, MO, MRK, NEM, NLSN, NOC, OSK, OSIS, OSTK, PBF, RGEN, RLGY, RS, SAH, SAIA, SNDR, SWI, SWK, TAP, TFX, TPX, TREE, TW, TXT, VC, VLY, WEX, WST, XEL, YUM Earnings After the Close: AAPL, ABCB, ACHC, AGL, AMZN, ASPN, ATEN, ATR, AVT, AX, BIO, BY, CDNA, CHE, COHU, COLM, CPT, CUZ, CWST, DECK, DVA, DXCM, EB, EMN, FISI, FTDR, FTV, GILD, HIG, HUBG, LOPE, LPLA, LTC, NGRC, MHK, MMSI, MPWR, MSTR, NATI, NXGN, PEB, POWI, PSB, PTCT, QUMU, RMD, RSG, SBCF, SBUX, SGEN, SKX, SKYW, SM, SPNE, SSNC, SYK, TEX, TXRH, VCRA, VRSN, WDC, WRAP, WRE, X, ZEN Macro Up/Down Last Nymex -1.61 81.05 Brent -1.37 83.21 Gold -2.10 1,801.20 EUR/USD -0.0006 1.1598 JPY/USD -0.23 113.57 10-Year Note +0.012 1.541% Sector News Breakdown Consumer eBay Inc. (EBAY) 3Q adj EPS $0.90 vs est. $0.89 on revs $2.5B vs est. $2.46B; guides 4Q adj EPS $0.72-0.76 vs est. $1.00, sees 4Q revs $2.57-2.62B vs est. $2.65B; raising estimated FY share buyback from $5.0B to $7.0B Ford Motor (F) announces resumption of stock dividend in 4q; 3Q adj EPS $0.51 vs est. $0.27 on revs $35.7B vs est. $32.5B; expects cash flow over current planning period to be more than sufficient to fund growth, announces resumption of regular stock dividend in 4Q; no changes to FY adj FCF guide of $4.0-5.0B Boot Barn (BOOT) Q2 EPS $1.25 vs est. $0.93 on revenue $312.7M (+67.1% vs 2Q19) vs est. $291M, same-store sales +61.7% YoY, +53.6% vs 2019; sees new unit growth 10% in FY22; named Jim Watkins as CFO with current CFO Greg Hackman continuing as VP and COO Churchill Downs (CHDN) 3Q EPS $1.57 vs est. $1.47 on revs $393Mm vs est. $406.8Mm Fresh Del Monte Produce Inc. (FDP) said it is raising prices on bananas, pineapples and fresh-cut fruit in response to unprecedented market conditions and inflationary pressures being felt across all industries iRobot (IRBT) Q3 EPS $1.67 vs. est. $0.70; Q3 revs $440.7M vs. est. $417.04M; cuts FY21 non-GAAP EPS view to $1.15-$1.74 from $2.25-$3.15 (est. $2.70) and lowers FY21 revenue view to $1.56B-$1.59B from $1.55B-$1.62B (est. $1.58B) Noodles (NDLS) Q3 adj EPS 12c vs est. 9c on in-line revenue $125.1M with digital sales 52% of total revs; system-wide comp sales +16.3% vs est. +14.3%, avg unit volume $1.38M, +16% YoY; now sees 7-9 new restaurants in 2021, down from prior outlook for 10-15; anticipates system-wide unit growth of at least 8% next year Oโ€™Reilly Auto (ORLY) Q3 EPS $8.07 vs. est. $7.18; Q3 sales $3.48B vs. est. $3.3B; gross profit margin 52.3% vs. 52.4% y/y; raises year rev outlook to $12.9B-$13.2B from prior $12.3B-$12.6B (est. $12.73B) Sleep Number (SNBR) 3Q EPS $2.22 vs est. $1.44 on revs $640Mm vs est. $587.1Mm; sees FY EPS $7.25 vs est. $7.15; Spirit Airlines (SAVE) Q3 adj EPS ($0.69) was a narrower loss than est. ($1.02) on in-line revs $922.6M; load factor 77.6%, capacity +3.5% vs 3Q19; is slowing the pace to push back to full fleet utilization, expects to produce 53B-55B available seat miles in 2022 VICI Properties (VICI) 3Q adj FFO/shr $0.45 on revs $375.7Mm; guides FY adj FFO/shr $1.7901.80 vs est. $1.84 Wyndham Hotels (WH) 3Q EPS $1.09 vs est. $0.91 on net revs $463Mm vs est. $463Mm; guides FY RevPAR growth about 43%, sees fee-related and other revs $1.21-1.23B; guides FY adj EPS $2.93-3.03 vs est. $2.69 Yum China (YUMC) Q3 adj EPS $0.22 vs. est. $0.31; Q3 revs $2.55B vs. est. $2.51B; qtrly total system sales increased 1% year over year, with increases of 1% at both KFC and Pizza Hut, excluding f/x; increasing gross new stores target to over 1,700 in 2021; expect that covid-19, especially the delta variant outbreaks, will continue to affect consumer behavior and impact our same-store sales recovery. Solo Brands, Inc. (DTC) prices 12.9M share IPO at $17.00 per share Scientific Games Corp (SGMS) announces sale of lottery business to Brookfield business partners for $6.05 billion; deal consisting of $5.825 bln in cash & an earn-out of up to $225 mln based on achievement of certain ebitda targets in 2022 & 2023 Energy, Industrials & Materials Allison Transmission (ALSN) 3Q EPS $0.89 vs est. $0.90 on revs $567Mm vs est. $584Mm; guides FY sales $2.325-2.4B vs est. $2.36B Flowserve Corp. (FLS) 3Q adj EPS $0.29 vs est. $0.40 on revs $866.1Mm vs est. $899Mm; guides FY revs down 2-4% vs est. -2.3%, sees FY EPS $1.45-1.65 (was $1.40-1.45) vs est. $1.58, sees CAPEX $70-80Mm vs prior $65Mm Kraton (KRA) Q3 adj EPS $0.98 vs. est. $0.79; Q3 revs $526.9M vs. est. $459.1M; Polymer segment operating income of $43.8 million, compared to an operating loss of $5.1 million YoY; Chemical segment operating income of $35.7M, compared to an operating loss of $401.7M YoY Sunnova Energy (NOVA) Q3 EPS ($0.25) vs est. ($0.13) on revenue $68.9M vs est. $67.4M; reaffirmed FY21 view for adj EBITDA $80M-$85M, customer additions 55k-58k; set FY22 guidance for adj EBITDA $117M-$137M, customer additions 83k-87k Tronox Holdings (TROX) Q3 adj EPS $0.72 vs. est. $0.64; Q3 revs rose 29% to $870M vs. est. $905.3M United Rentals (URI) 3Q adj EPS $6.58 vs est. $6.80 on revs $2.6B vs est. $2.58B; guides FY revs $9.6-9.75B vs est. $9.6B, sees FY adj EBITDA $4.325-4.4B vs est. 4.3B Financials Aflac (AFL) Q3 adj EPS $1.53 vs. est. $1.32; Q3 revs $5.2B vs. est. $5.34B; in yen terms, Aflac Japanโ€™s net premium income was ยฅ323.1 bln for quarter, or 4.0% lower than a year ago AvalonBay (AVB) Q3 core FFO $2.06 vs est. 1.97, EPS $0.56 vs est. $0.77, same-store sales +1.2%; sees Q4 core FFO $2.19-$2.29 vs est. $2.11, raised FY core FFO view to $8.18-$8.28 from $7.92-$8.12 CyrusOne Inc. (CONE) 3Q adj FFO/shr $1.02 vs est. $0.99 on revs $304.1Mm vs est. $290.4Mm; guides FY revs $1.18-1.2B vs est. $1.17B Invitation Homes (INVH) Q3 core FFO 38c/shr vs est. 36c, EPS 12c vs est. 10c, revenue $510M vs est. $497.8M; same-store NOI +11.9% YoY on same-store revs +7.9%; raised FY21 core EPS view to $1.49 at midpoint from $1.44, adj FFO ro $1.28 at midpoint from $1.24 Lending Club (LC) Q3 EPS $0.26 vs est. $0.03 on revenue $246.2M vs est. $221.2M; sees Q4 revs $240M-$250M vs est. $235.7M, loan originations $2.8-$3B; raised FY view for revenue to $796M-$806M from $750M-$780M Raymond James (RJF) Q4 EPS $2.06 vs. est. $1.71; Q4 revs $2.7B vs. est. $2.54B; quarter-end records for client assets under administration of $1.18 trillion, financial assets under management of $191.9B, and net loans at Raymond James Bank of $25B The SEC asked at least one asset manager not to proceed with plans for a leveraged bitcoin exchange-traded fund, according to a person familiar with the matter. The SEC indicated it wants to limit new bitcoin-related products to those that provide unleveraged exposure to bitcoin futures contracts, such as the ProShares Bitcoin Strategy exchange-traded fund, which was launched last week, the person said. https://on.wsj.com/3GvG2qg Healthcare Align Technology (ALGN) 3Q adj EPS $2.87 vs est. $2.60 on revs $1.02B vs est. $978Mm; guides FY revs $3.9-3.95B vs est. $3.94B; says clinical study validates benefits of the Itero Element 5D imaging system Alnylam (ALNY) reports positive topline 18-month results from Helios-a phase 3 study of Vutrisiran in patients with HATTR amyloidosis with polyneuropathy BioMarin (BMRN) Q3 GAAP EPS loss (-$0.20) vs. est. loss (-$0.25); Q3 revs $408.7M vs. est. $435.32M; Lower Kuvan product revenues primarily due to generic competition due to the loss of exclusivity in the U.S.; Lower Aldurazyme product revenues due to timing of product fulfillment to Genzyme Edwards LifeSciences (EW) Q3 EPS $0.54 vs. est. $0.53; Q3 revs $1.3B vs. est. $1.32B; sees FY21 adjusted EPS at high end of $2.07-$2.27 (est. $2.26) and reaffirms FY21 revenue view $5.2B-$5.4B (est. $5.32B); TAVR sales grew 15%; underlying 14%; U.S. TAVR sales grew 12%; OUS approximately 20% Encompass Health (EHC) Q3 adj EPS $1.03 vs. est. $1.06; Q3 revs $1.28B vs. est. $1.31B; cuts FY21 adj EPS view to $4.23-$4.38 from $4.32-$4.47 and lowers FY21 revenue view to $5.08B-$5.13B from $5.1B-$5.25B (est. $5.18B) Molina Healthcare (MOH) Q3 adj EPS $2.83 vs. est. $2.79; Q3 revs $7.04B vs. est. $6.79B; backs FY21 EPS view of no less than $13.25 vs. est. $13.38 and backs FY21 revenue view of no less than $27.5B vs. est. $26.97B; consolidated MCR for Q3 was 88.9%, compared to 85.9% in the third quarter of 2020 Teladoc (TDOC) Q3 EPS loss (-$0.53) vs. est. loss (-$0.65); Q3 revs $521.66M vs. est. $516.6M; Q3 visits topped 3.9M, 37% higher than Q3 2020; sees Q4 EPS loss (73c)-(53c) vs. est. loss (69c); sees Q4 revs $536M-$546M vs. est. $539.74M; sees Q4 total visits 3.9M-4.1M

119 Replies 9 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@Benlax #droscrew
recently

$DXCM breaking out today of a post-earnings bull flag and seeing spreads sell the December $470 puts to buy the $560/$660 call spread 600X for a net $10.50

89 Replies 14 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

I've had 5 high conviction trades the past 2 months, meaning on my scale of 1 to 5 trade set ups that met 5 stars. SAVA, DXCM, SWBI, NTLA, & MP SAVA netted me a 600% return, DXCM 450%, SWBI 500%, NTLA I didn't trade because of confusion of dates, and MP just didn't work. So I'm 3/5 for those, and these have allowed each account to sit comfortably

113 Replies 15 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Pyrognosis #droscrew
recently

PANW,MELI,DXCM,RGEN,BIIB,BK,SNPS,GOOG,CSCO,TEAM,CTSH,CDW,LULU,ORLY,GILD,NVDA,CHTR,AMD,EBAY,XLNX,LOW,WMT,PFE,MRNA,

113 Replies 12 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

1700 $DXCM SEP2021 $570 Cs trade 1.75

96 Replies 6 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

1700 $DXCM SEP2021 $570 Cs trade 1.75

74 Replies 8 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

@Kendo257 DXCM, LC, TEAM top moves i saw today all earnings winners or price target raises

120 Replies 15 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

@buythedip do you remember DXCM?

49 Replies 12 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

not closing QROVO 210 or GOOG 1620 calls as these are clapped, congrats if you cught QSI, TMO DXCM over 120% minimum on each max 600% if you held DXCM to 448 i got out too late lol

91 Replies 14 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

Sold DXCM 450 3.75

127 Replies 15 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

congrats if you've held those free DXCM 450 calls with me since 06/14 we're still holding free contracts from 1.95 to currently 7.70

146 Replies 12 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM almost to PT

63 Replies 7 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM $9 away from being ITM, free play continues to run the bag

150 Replies 10 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

Still holding the free DXCM swing , MP, and QSI

76 Replies 8 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

NOTHING BUT HITS QSI, MP, MU, TMO, all positions are green and over 20% minimum. only red position is ADSK. DXCM ie red today but we're still over 200%

130 Replies 7 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

**1) DXCM (Dexcom)** DXCM as this is also a active trade, also present another opportunity with a new breakout that is occurring. This is breakout is occurring with institutional interest. DXCM has large institutional ownership. We will be implementing our market exploit strategy for this continuation. Due to this having large institutional ownership and we received a great deal of volume when this fell in a 24 hr span from $439 to $419, Institutions recognized quickly a 1% discount. Due to this large buying pressure expect for continuation from the accumulation. For a safe entry watch for the break above thursday's open at $433 for a swing. PT remains $450 as this is also an active trade we are over 200% on

81 Replies 14 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

who else is holding those DXCM $450 with me for July you should be up 170% right now

45 Replies 6 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

has anybody looked at the number 1 play on this week's watchlist, I know i was extra focused on the DXCM gap fill but NOW was a 700% play from the $515 level contracts ran from $340 a contract to as high as $2150 a contract currently $1900

69 Replies 15 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

who else is holding those free DXCM 07/16 450 calls

86 Replies 11 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM has competed the gap fill at $418, $420 will show strength and continuation

136 Replies 11 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

Sold DXCM 06/18 420 call 1.65 as greed and theta qent against this. taking small profits as this was up 200% and theta and sideways action is giving profit back. will eye power hour or tomorrow for opportunity to complete trade of the gap fill

119 Replies 13 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

took profit on DXCM $410 call at $415, allowed the one minute to trick me out of my plan of exit lol, profit is profit

109 Replies 7 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

large prints came in on DXCM just now

109 Replies 9 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM sold 410 call for 6.00

67 Replies 9 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM is at the evel we wanted, if this breaks we can see $420 shortly

111 Replies 15 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM 410 ITM and pushing still looking for $420

113 Replies 13 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM approaching key level at 410

143 Replies 9 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM accumulating for another leg up

148 Replies 10 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM just received a huge push

59 Replies 11 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

going to be a fun morning, yesterday's market action allowed us a wider range for today, I'm still watching the same things DXCM, ADBE, ASTS, AMC also my long positions on MP and TTCF for opportunities to add

119 Replies 13 ๐Ÿ‘ 10 ๐Ÿ”ฅ

BU
@buythedip #marketassasins
recently

@marketjay looking good to enter dxcm here??

137 Replies 9 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM 06/18 $410 3.30 call as per plan continued exploiting the gap fill

77 Replies 11 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM 06/18 $420 CALLS 1.40 (bounce play for the small account) TP: $415 continous gap fill play

100 Replies 12 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

sold remaining DXCM 06/18 2.00 no holding for the $420 calls

40 Replies 12 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM 07/16 sold 8 contracts 2.50 remaining 2 contracts are free, may add to position when market re balances (AGAIN VERY IMPORTANT RISK MANAGEMENT)

79 Replies 9 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

Sold 10 contracts of the $420 calls at 2.61, gave back some profit as this was 3.60 a contract but still over 120% remaining 3 contracts are free (RISK MANAGEMENT VERY IMPORTANT)

108 Replies 7 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

Wall broken on DXCM

91 Replies 14 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM still wants to push

89 Replies 8 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM NTLA favorable momentum

109 Replies 9 ๐Ÿ‘ 9 ๐Ÿ”ฅ

BU
@buythedip #marketassasins
recently

This dirty little bitch man. I went to limit sell one of my DXCM at 2.60 to lock in profits on one and it didn't go through, so I retried to submit at 2.50 and it sold my last two and my last one did ACTUALLY go through... fuck ๐Ÿคฆโ€โ™‚๏ธ this is why you never trade within the first 10 mins, broke my own rule..

136 Replies 11 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

Currently NOW is a voided trade off the watchlist as it played out the way we wanted yesterday, MSTR already achived, ATVI and REGN have not met criteria yet, HON, NTLA, and DXCM all active, ADBE moving strongly but I will be waiting for earnings

52 Replies 15 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM pulled to yesterday's close and rose to $410, I will start off loading some at $414

150 Replies 7 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM is the main holding for the gap fill

96 Replies 9 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

And swing trade DXCM, NTLA, and HON

111 Replies 14 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

Hourly breakout confirmed on DXCM

104 Replies 15 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

Momentum been building on DXCM gradually since this morning, also unusual option activity found

62 Replies 7 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

DXCM 07/16 $450 CALLS 1.95, as DXCM works to fill the gap, they may become extremely volatile as fundamentals show they've only recently become profitable, expect data showing large profit margins from their sensors

75 Replies 12 ๐Ÿ‘ 14 ๐Ÿ”ฅ

Key Metrics

Market Cap

28.37 B

Beta

1.46

Avg. Volume

1.15 M

Shares Outstanding

98.13 M

Yield

0%

Public Float

0

Next Earnings Date

2022-07-28

Next Dividend Date

Company Information

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

CEO: Kevin Sayer

Website:

HQ: 6340 Sequence Dr San Diego, 92121-4356 California

Related News